Hybrigenics has extended its partnership with Servier to discover new drugs which inhibit Ubiquitin-Specific Proteases, or USPs. This partnership was initiated in October 2011.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0098 EUR | +2.08% | -1.01% | -55.86% |
07/05 | ATON board of directors chooses Uguzzoni as CEO and appoints Nervosi as vice chairman | AN |
22/03 | ATON Green Storage, profit halved in 2023 and revenues drop | AN |
1st Jan change | Capi. | |
---|---|---|
-55.86% | 4.3M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- ALHYG Stock
- News ATON
- Hybrigenics Extends Partnership with Servier for USPs Inhibitors